Drug Channels

APRIL 9, 2025

Read more 2006-2025 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. While some major companies have narrowed their focus or unwound previous integration efforts, ongoing consolidation and selective deconsolidation will continue to reshape the healthcare biome by trying to build something epic, block by block.

Specialty Pharmacies 98

Specialty Pharmacies 98

Drug Channels

JUNE 19, 2025

Read more » © 2006-2025 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. While some major companies have narrowed their focus or unwound previous integration efforts, ongoing consolidation and selective deconsolidation will continue to reshape the healthcare biome by trying to build something epic, block by block.

Specialty Pharmacies 52

Specialty Pharmacies 52

Drug Channels

JUNE 16, 2025

Read more » © 2006-2025 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. For a sneak peek at the complete report, click here to download our free 30-page report overview (including key industry trends, What's New in this edition, the Table of Contents, and a List of Exhibits). All rights reserved.

Specialty Pharmacies 52

Specialty Pharmacies Drug Pricing 52

Drug Channels

DECEMBER 3, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. And don't forget to put on your ruby slippers and hear from Doctor of Thinkology Adam J. During next week’s Drug Channels Outlook 2025 live video webinar, he'll tell you what's ahead for the program that continues to defy gravity.

Drug Pricing 52

Drug Pricing Hospitals 52

Drug Channels

JULY 8, 2025

Read more » © 2006-2025 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. In this post, I examine how the major PBMs—and some of the smaller ones—are handling Stelara biosimilars, what’s changed since the Humira experience, and why their strategies reflect the growing dominance of private-label rebating schemes.

Biosimilars 52

Biosimilars Labelling 52

Drug Channels

JANUARY 22, 2025

Read more 2006-2025 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. But the PBMs strategies, combined with the warped incentives baked into the Inflation Reduction Act, raise questions about the viability of the biosimilar marketplace. What do you think? All rights reserved.

Labelling 98

Labelling Biosimilars 98

Drug Channels

JUNE 24, 2025

Read more » © 2006-2025 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. P.S. Join my nearly 64,000 LinkedIn followers for daily links to neat stuff, along with sharp and thoughtful commentary from the Drug Channels community. All rights reserved. This Feed is for personal non-commercial use only.

40

40

Drug Channels

JUNE 13, 2025

Read more » © 2006-2025 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. In this article, they present a six-step framework to help manufacturers align clinical development with payer expectations, patient needs, and real-world access dynamics. Read on for Sean and Carolyn’s insights. All rights reserved.

52

52

Drug Channels

APRIL 25, 2025

Read more 2006-2025 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Drawing on fresh 2025 plan data, he highlights the emerging barriers faced by patients, the shifting demands on providers, and the strategic implications for drug manufacturers. Read on for Scotts insights. All rights reserved.

52

52

Drug Channels

JULY 11, 2025

Read more » © 2006-2025 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. She argues that emerging Direct-to-Patient (DTP) strategies can reshape the care experience by addressing longstanding inefficiencies, enhancing transparency, and simplifying therapy initiation for both patients and providers.

52

52

Drug Channels

APRIL 4, 2025

Read more 2006-2025 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. New channel modelsincluding smaller PBMs, cost-plus pharmacies, patient-paid discount card prescriptions, and manufacturers direct-to-patient businessesare creating novel paths for drugs that can be sold without gross-to-net bubble distortions.

Drug Pricing 52

Drug Pricing 52

Express Pharma

FEBRUARY 3, 2025

Shanghvi has been with Sun Pharma since 2006, holding various roles across marketing, research and development (R&D), project management, procurement, and communications. The company announced the designation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Communication 66

Communication 66

Drug Channels

FEBRUARY 18, 2025

Read more 2006-2025 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Thanks to the Inflation Reduction Act (IRA), the PDP market is vanishing. Looks like the presence of smaller pharmacies in preferred networks will not be far behind. All rights reserved. This Feed is for personal non-commercial use only.

Independent Pharmacies 52

Independent Pharmacies 52

Pharmacy Times

JUNE 27, 2025

's 2006 study highlighted psilocybin's potential to induce meaningful mystical experiences, sparking renewed research interest. The relevance of the 2006 study by Griffiths et al cannot be overstated. Historical studies, like Grof et al.'s Griffiths et al.'s

Pharmacy Technician 20

Pharmacy Technician Compounding Pharmacies Pharmacy Management Diabetes 20

Drug Channels

FEBRUARY 7, 2025

Read more 2006-2025 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. To learn more, download PANTHERxs latest white paper and SP decision-support resource: Selecting the Right Specialty Pharmacy Partner for a Successful Launch. Read on for Richards insights. All rights reserved.

Specialty Pharmacies 64

Specialty Pharmacies 64

Drug Channels

APRIL 23, 2025

Read more 2006-2025 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. They dominate exclusive networks and maybe even cleaning up any messes left by Things 1, 2, and 3. Read on for DCIs updated profile of specialty networksand consider why smaller players are showing the good tricks that they know.

Specialty Pharmacies 72

Specialty Pharmacies Independent Pharmacies Pharmaceutical Manufacturing 72

Drug Channels

APRIL 1, 2025

Read more 2006-2025 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. But the PBMs strategies, combined with the warped incentives baked into the Inflation Reduction Act, raise questions about the viability of the biosimilar marketplace. What do you think? All rights reserved.

Labelling 52

Labelling Biosimilars 52

Drug Channels

JANUARY 7, 2025

Read more 2006-2025 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. New channel modelsincluding smaller PBMs, cost-plus pharmacies, patient-paid discount card prescriptions, and manufacturers direct-to-patient businessesare creating novel paths for drugs that can be sold without gross-to-net bubble distortions.

Drug Pricing 90

Drug Pricing 90

Drug Channels

DECEMBER 9, 2024

Read more 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. But whats really going to bake your noodle later: Would the largest PBMs have popped the gross-to-net bubble for Humira if they hadnt been able to profit from the switch? All rights reserved. This Feed is for personal non-commercial use only.

Biosimilars 52

Biosimilars Labelling 52

Drug Channels

NOVEMBER 4, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. drug channel system is warping hospitals’ incentives to adopt biosimilars, while simultaneously raising costs for commercial plans. The namesake of my alma mater once said: “Sunlight is said to be the best of disinfectants.” All rights reserved.

Biosimilars 98

Biosimilars Hospitals 98

Drug Patent Watch

JANUARY 13, 2025

Similarly, the European Medicines Agency (EMA) has been at the forefront of biosimilar regulation, with a well-established approval process in place since 2006. In the United States, the FDA has established a robust pathway for biosimilar approval through the Biologics Price Competition and Innovation Act (BPCIA).

Biosimilars 59

Biosimilars Diabetes 59

Drug Channels

JANUARY 28, 2025

Read more 2006-2025 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. I recently passed 60,000 LinkedIn followers. If you havent done so already, follow along for my daily links to neat stuff along with thoughtful and provocative commentary from the DCI community. All rights reserved.

Hospitals 59

Hospitals 59

Pharmaceutical Business Review

JULY 8, 2025

” Sagent Pharmaceuticals, established in 2006, is a provider of generic and specialty pharmaceuticals. With a portfolio exceeding 100 products, Sagent offers a wide range of options across various therapeutic categories, formulations, and packaging configurations, such as vials, syringes, and premix bags.

Dosage 52

Dosage Packaging Biosimilars Pharmaceutical Companies 52

European Pharmaceutical Review

JUNE 27, 2025

She completed her PhD in biochemistry in 2006 at Cardiff University, UK, focusing on cell therapy, before starting with a postdoc and two fellowship positions in stem/stromal cell biology.

Drug Pricing 52

Drug Pricing 52

Drug Channels

JUNE 10, 2025

Read more » © 2006-2025 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. For more on what the 340B program’s growth means for pharmacies, join Adam J. Fein, Ph.D., and Antonio Ciaccia on June 20 for a new live video webinar: What’s Next for Retail Pharmacy: Data, Debate, and Disruption. All rights reserved.

Drug Pricing 59

Drug Pricing Hospitals 59

Drug Channels

APRIL 16, 2025

Read more 2006-2025 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. We also explore how these pharmacies contribute to PBMs profitabilityand spotlight the growing influence of provider- and health system-owned dispensing channels. Once again, specialty mostly means affiliated with a PBM. What do you think?

Specialty Pharmacies 40

Specialty Pharmacies 40

Drug Channels

NOVEMBER 19, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Fein, Ph.D., for his upcoming live video webinar, Drug Channels Outlook 2025 , on December 13, 2024, from 12:00 p.m. to 1:30 p.m. Click here to learn more and sign up. All rights reserved. This Feed is for personal non-commercial use only.

Documentation 97

Documentation 97

Drug Channels

NOVEMBER 13, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Find out during my upcoming live video webinar, Drug Channels Outlook 2025 , on December 13, 2024, from 12:00 p.m. to 1:30 p.m. Click here to learn more and sign up. All rights reserved. This Feed is for personal non-commercial use only.

98

98

Express Pharma

MARCH 19, 2025

These certifications, coupled with WHO-GMP certifications and many others (held since 2006), reinforce Sovereign Pharmas dedication to time-tested and globally trusted manufacturing standards. Likewise, the UKs MHRA approved the companys terminally sterilised small volume liquids for vials.

85

85

Drug Channels

FEBRUARY 4, 2025

2006-2025 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. For more on the forces of change affecting drug distribution and the buy-and-bill market, see Chapter 6 of DCIs recent 2024-25 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. All rights reserved.

Biosimilars 52

Biosimilars 52

RX Note

MARCH 31, 2025

External Links American Academy of Dermatology Association - Cold Sores Antiviral activity of Australian tea tree oil and eucalyptus oil against herpes simplex virus in cell culture, 2001 Natural remedies for Herpes simplex, 2006 Randomized clinical study comparing Compeed cold sore patch to acyclovir cream 5% in the treatment of herpes simplex labialis, (..)

Community Pharmacies 52

Community Pharmacies Chemotherapy 52

Drug Channels

DECEMBER 12, 2024

Read more 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Todays article is adapted from Chapter 3 of DCIs forthcoming 2024-25 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors , which will be available to preorder next week at special introductory pricing. All rights reserved.

Specialty Pharmacies 52

Specialty Pharmacies Hospitals 52

Drug Channels

JUNE 3, 2025

Read more 2006-2025 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Fein and Antonio Ciaccia will unpack the good, the bad, and the ugly of the pharmacy industryand explore what it means for you. This dynamic session will blend expert insights and real-time debate. Click here to register. All rights reserved.

Hospitals 52

Hospitals 52

Drug Channels

APRIL 27, 2025

Read more 2006-2025 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Join nearly 63,000 of your peers who follow me on LinkedIn for daily insights, links to neat stuff, and sharp commentary from the ever-engaged DCI community. Live from Asembias AXS25 Summit : The DCI team is on-site! Swing by booth #1601 at 4 p.m.

52

52

Drug Channels

APRIL 2, 2025

Read more 2006-2025 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. But Minnesotas report marks a valuable first step on the yellow brick road to the wonderful world of transparency. I suspect similar reports are gonna be popular. All rights reserved. This Feed is for personal non-commercial use only.

Drug Pricing 52

Drug Pricing Hospitals 52

Drug Channels

JUNE 20, 2025

Read more » © 2006-2025 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Federal efforts haven’t been much better. Should we continue down the path of government-mandated reporting, or should plan sponsors be left to negotiate their own deals? All rights reserved. This Feed is for personal non-commercial use only.

80

80

Drug Channels

NOVEMBER 7, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. To learn more, register for ConnectiveRx’s free webinar on December 11: The Perfect Storm? Patient Support Programming in 2025 and Beyond. Read on for Chris’s insights. All rights reserved. This Feed is for personal non-commercial use only.

97

97